Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SelenBio is a biotechnology company specializing in the development of antimicrobial technologies based on the element selenium. The company's core platform, Selen-X, incorporates selenium into various materials to prevent the formation of bacterial biofilms without the use of traditional antibiotics. Their primary commercial focus is in the dental industry, where they offer products like DenteShield to prevent tooth decay and white spot lesions. Beyond dentistry, SelenBio is exploring applications in medical devices, wound care, and industrial coatings to combat persistent bacterial infections. The technology is unique because the selenium is covalently bonded to the material, ensuring it does not leach out and remains effective for the life of the product.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SelenBio.